PRKDC and hepatocellular carcinoma: Aberrant expression of DNA-PKcs conveys oncogenic properties in HCC with upregulation of DNA-PKcs significantly elevated in tumors compared to normal tissue [99], and a second study classified DNA-PKcs as a candidate driver in hepatocarcinogensis, with amplification of the PRKDC locus and increased mRNA expression found in HCC [100].